The JULI Registry--Hemp and Cannabis Observational Registry
Unknown statusNCT04726254
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The JuLi Registry seeks to fill some of the gaps associated with the clinical use of CBD (cannabidiol) and other cannabinoid formulations including THC and others. The overarching goal of this Registry is to rapidly advance research and understanding of the use of cannabis and hemp-based formulations, in the clinical community setting, when it is utilized to manage the symptoms of cancer treatment and other underlying health issues. These symptoms include nausea, neuropathy, and sleeplessness and chronic pain.
Study details
- Official title
- The JUvaLIfe Registry
- Conditions
- Chronic Pain
- Appetite Disorders
- Neuropathy
- Menopausal Syndrome
- Anxiety
- Sleep Disturbance
- Nausea
- Sponsor
- Juva Life
- Collaborators
- Targeted Medical Education
- Start date
- 2021-08-01
- Primary completion
- 2024-02-15
- Sex
- All
- Age range
- from 21 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 4
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 21 years of age or older * Have requested from and/or decided with their providers to try CBD (hemp-based) or other cannabis products to relieve one or more symptoms related to a medical diagnosis * Consent to have their health data included in a Registry and participate in PRO (patient reported outcomes) surveys and data collection via a study app. Exclusion Criteria: * Patient pregnant * Unwilling or unable to provide informed consent
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04726254